Delivery Order SPE2DB22D1106-SPE2DB24FEPA2
Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $3.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,026.03 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a period of performance through July 15, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,311.60 contract is for the supply of the drug MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a $29,820.51 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Amerisourcebergen's single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $3,156.00 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm-Fixed Price Delivery Order contract worth $7,890.00 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $2,104.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The delivery order is for MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of February 21, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,156.00 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. This contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period through May 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up...
- The Defense Logistics Agency (DLA) awarded a $3,208.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract has a completion date of May 14, 2024 and was awarded on May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,269.99 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency (DLA) awarded a $1,630.44 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit company Amerisourcebergen Corporation. The contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEPA2Delivery Order
The Defense Logistics Agency (DLA) awarded a $3,419.00 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a leading pharmaceutical distributor. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Generated 7/29/24, 9:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 4/29/24 |